Plant Health to evaluate London listing as stock levels ‘frustrate’ board
Plant Health Care said on Tuesday its board will evaluate if the firm should continue to be listed on the LSE’s Alternative Investment Market (AIM) as it was “frustrated” with the share performance not reflecting its strategic progress.